Archives

by in
Entry Author Date Location
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
Biotech Wasn’t Immune to Job Loss in Great Recession, BIO Report Says 06/19/12 National
Join Kevin Starr, Corey Goodman, Carl Weissman & More in Seattle April 3 01/19/12 Seattle
Forma Reels In J&J With $700M Deal; 2nd Cancer Drug Discovery Partner in a Week 01/10/12 Boston
Forma Cuts $65M Deal With Boehringer Ingelheim to Discover Cancer Drugs 01/05/12 Boston
Page 1 of 1